Meet five ‘HIV controllers,’ some positive for decades, who may hold clues to ending AIDS
Dec. 14, 2015
| By Mary Engel / Fred Hutch News Service
Rod Fichter’s story of surviving while his partner died of AIDS was the emotional centerpiece of the HBO VICE Special Report, "Countdown to Zero." Multiply his story by 100 and you will begin to understand the exceptional volunteers who are part of a long-running Fred Hutch study on people with HIV who control the virus without medication.
Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
April 9, 2012
Fred Hutchinson Cancer Research Center researchers played a key role in the discovery of important immune responses that may have protected some volunteers from HIV in the RV144 Thai trial, the first HIV vaccine trial to show modest effectiveness in preventing HIV infection. Results from extensive RV144 laboratory studies were published April 5 in the New England Journal of Medicine.
Science magazine selected HIV prevention trial for its top honor of 2011; study showed early antiretroviral therapy reduced heterosexual HIV transmission by 96 percent
Jan. 9, 2012
| By Colleen Steelquist and Dean Forbes
The Hutchinson Center's Statistical Center for HIV/AIDS Research & Prevention (SCHARP) played a key role in the HIV prevention study that Science magazine recently chose as its scientific breakthrough of the year for 2011.
Citing a new study from Uganda, Dr. Judith Wasserheit's New England Journal of Medicine editorial concludes 'circumcision offers an important prevention opportunity and should be widely available'
March 30, 2009
According to an editorial by Dr. Judith Wasserheit, of the Fred Hutchinson Cancer Research center Clinical Research Division and the Vaccine and Infectious Disease Institute, co-authored by Dr. Matthew Golden of the University of Washington Center for AIDS and STD and the Seattle-King County Public Health Department’s STD Control Program, circumcision of adult and newborn males is an important tool for preventing HIV and other sexually-transmitted diseases and should be made widely available in areas of high disease prevalence around the world, according to a recent editorial in last week’s New England Journal of Medicine.